Up­dat­ed: Trou­bled Emer­gent claims J&J will owe up to $420M if it pulls the plug on its Covid-19 vac­cine

Em­bat­tled con­tract man­u­fac­tur­er Emer­gent BioSo­lu­tions, which trashed tens of mil­lions of J&J’s Covid-19 vac­cine dos­es be­cause of its con­t­a­m­i­nat­ed Bal­ti­more plant, is now telling J&J that it will have to pay some­where in the range of $125 mil­lion to $420 mil­lion if it ter­mi­nates its Covid man­u­fac­tur­ing con­tract with Emer­gent.

In an SEC fil­ing Mon­day, Emer­gent said that it pro­vid­ed Janssen with “a no­tice of ma­te­r­i­al breach” be­cause Janssen is es­sen­tial­ly wind­ing down its Covid-19 vac­cine op­er­a­tions be­fore ful­fill­ing the min­i­mum re­quire­ments in its con­tract with Emer­gent.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.